Tiber Creek Partners, LLC provides detailed business analysis, strategic planning, and substantive content, including scientific input, to biotechnology companies that seek to use non-dilutive capital from the U.S. Government, foreign governments, and non-governmental organizations as part of their commercialization objectives. We offer a full understanding of funding and procurement opportunities and provide the strategy and materials necessary to communicate the advantages and the state of development of our clients’ technology so that it resonates most effectively with funding and purchasing decision-makers.
